Novel orexigenic pathway prostaglandin D2-NPY system - Involvement in orally active orexigenic δ opioid peptide

Neuropeptides

Volumn 46, Issue 6, 2012, Pages 353-357

  Kaneko, Kentaro ^a   Yoshikawa, Masaaki ^a   Ohinata, Kousaku ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Opioid receptor; COX 2; DP1 receptor; Food intake; L PGDS; Leptomeninges; NPY; PGD2; Rubiscolin 6; Y1 receptor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ARACHIDONIC ACID; DELTA OPIATE RECEPTOR; NEUROPEPTIDE Y; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2;

ARTICLE; BODY FAT; BODY WEIGHT; FOOD INTAKE; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APPETITE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MENINGES; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, OPIOID, DELTA; RECEPTORS, PROSTAGLANDIN; RIBULOSE-BISPHOSPHATE CARBOXYLASE;

MUS;

EID: 84869873093     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.10.003     Document Type: Article

References (51)

1. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 1998, 9(10):2265-2267.
2. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120(2):337-345.
3. Blomqvist A.G., Herzog H. Y-receptor subtypes: how many more?. Trends Neurosci. 1997, 20:294-298.
4. Brantl V., Teschemacher H., Henschen A., Lottspeich F. Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seylers Z Physiol. Chem. 1979, 360(9):1211-1216.
5. Bzdega T., Chin H., Kim H., Jung H.H., Kozak C.A., Klee W.A. Regional expression and chromosomal localization of the δ opiate receptor gene. Proc. Natl. Acad. Sci. U S A 1993, 90(20):9305-9309.
6. Davoust N., Jones J., Stahel P.F., Ames R.S., Barnum S.R. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 1999, 26(3):201-211.
7. Ellis R.J. The most abundant protein in the world. Trends Biochem. Sci. 1979, 4:241-244.
8. Everson C.A., Bergmann B.M., Rechtschaffen A. Sleep deprivation in the rat: III. Total sleep deprivation. Sleep 1989, 12(1):13-21.
9. Fukudome S., Yoshikawa M. Opioid peptides derived from wheat gluten: their isolation and characterization. FEBS Lett. 1992, 296(1):107-111.
10. Gasque P., Singhrao S.K., Neal J.W., Götze O., Morgan B.P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 1997, 150(1):31-41.
11. Gasque P., Dean Y.D., McGreal E.P., van Beek J., Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 2000, 49(1-2):171-186.
12. Gray A.C., Coupar I.M., White P.J. Comparison of opioid receptor distributions in the rat central nervous system. Life Sci. 2006, 79(7):674-685.
13. 2. FASEB J. 1991, 5(11):2575-2581.
14. 2 system. J. Appl. Physiol. 2002, 92(2):863-868.
15. Hayaishi O., Urade Y., Eguchi N., Huang Z.L. Genes for prostaglandin D synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation to NREM sleep. Arch. Ital. Biol. 2004, 142:533-539.
16. 1 receptors. Peptides 2007, 28(10):1998-2003.
17. Hou I.C., Yoshikawa M., Ohinata K. β-lactotensin derived from bovine β-lactoglobulin suppresses food intake via the CRF system followed by the CGRP system in mice. Peptides 2009, 30(12):2228-2232.
18. Huang Z.L., Urade Y., Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 2007, 7(1):33-38.
19. Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved?. Trends Pharmacol. Sci. 1999, 20:43-46.
20. Kalra S.P., Dube M.G., Fournier A., Kalra P.S. Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol. Behav. 1991, 50(1):5-9.
21. B systems. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299(3):799-805.
22. Kaneko, K., Lazarus, M., Miyamoto, C., Oishi Y., Nagata, N., Yang, S., Yoshikawa, M, Aritake, K., Furuyashiki, T., Narumiya, S., Urade, Y., Ohinata, K., in press. Orally administered rubiscolin-6, a δ opioid peptide derived from Rubisco, stimulates food intake via leptomeningeal lipocallin-type prostaglandin (PG) D synthase in mice. Mol. Nutr. Food Res. 56 (8), 1315-1323.
23. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402(6762):656-660.
24. Law S.K., Reid K.B. Complement 1995, IRL Press, Oxford OX1 3QU, UK. 2nd ed.
25. Lin L., Chen J., York D.A., Bray G.A. β-Casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides 1998, 19(2):325-331.
26. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18(1):22-29.
27. Marczak E.D., Ohinata K., Lipkowski A.W., Yoshikawa M. Arg-Ile-Tyr (RIY) derived from rapeseed protein decreases food intake and gastric emptying after oral administration in mice. Peptides 2006, 27(9):2065-2068.
28. Morley J.E. Anorexia of aging: physiologic and pathologic. Am. J. Clin. Nutr. 1997, 66(4):760-773.
29. Morley J.E., Thomas D.R. Anorexia and aging: pathophysiology. Nutrition 1999, 15(6):499-503.
30. Morley J.E. Anorexia, sarcopenia, and aging. Nutrition 2001, 17(7-8):660-663.
31. Nadeau S., Rivest S. The complement system is an integrated part of the natural innate immune response in the brain. FASEB J. 2001, 15(8):1410-1412.
32. 2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 1982, 31(19):2093-2103.
33. Nataf S., Stahel P.F., Davoust N., Barnum S.R. Complement anaphylatoxin receptors on neurons: new tricks for old receptors?. Trends Neurosci. 1999, 22(9):397-402.
34. O'Barr S.A., Caguioa J., Gruol D., Perkins G., Ember J.A., Hugli T., Cooper N.R. Neuronal expression of a functional receptor for the C5a complement activation fragment. J. Immunol. 2001, 166(6):4154-4162.
35. Ohinata K., Inui A., Asakawa A., Wada K., Wada E., Yoshikawa M. Albutensin A and complement C3a decrease food intake in mice. Peptides 2002, 23(1):127-133.
36. 4 subtype suppresses food intake in mice. Prostaglandins Other Lipid Mediat. 2006, 81(1-2):31-36.
37. Ohinata K., Suetsugu K., Fujiwara Y., Yoshikawa M. Suppression of food intake by a complement C3a agonist [Trp5]-oryzatensin(5-9). Peptides 2007, 28(3):602-606.
38. 2 stimulates food intake via the neuropeptide Y system in mice. FEBS Lett. 2008, 582(5):679-684.
39. 2- and neuropeptide Y-dependent mechanism in mice. Prostaglandins Other Lipid Mediat. 2009, 90(3-4):81-84.
40. Oida H., Hirata M., Sugimoto Y., Ushikubi F., Ohishi H., Mizuno N., Ichikawa A., Narumiya S. Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain. FEBS Lett. 1997, 417(1):53-56.
41. 2, are correlated with increasing propensity towards sleep in rats. Brain Res. 1997, 751(1):81-89.
42. 2 in rats. Proc. Natl. Acad. Sci. U S A 1996, 93(12):5980-5984.
43. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404(6778):661-671.
44. Sherin J.E., Elmquist J.K., Torrealba F., Saper C.B. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 1998, 18(12):4705-4721.
45. Takeda H., Muto S., Hattori T., Sadakane C., Tsuchiya K., Katsurada T., Ohkawara T., Oridate N., Asaka M. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 2010, 151(1):244-252.
46. van Beek J., Elward K., Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N. Y. Acad. Sci. 2003, 992:56-71.
47. White C.L., Bray G.A., York D.A. Intragastric β-casomorphin1-7 attenuates the suppression of fat intake by enterostatin. Peptides 2000, 21(9):1377-1381.
48. Yang S., Yunden J., Sonoda S., Doyama N., Liplowski A.W., Kawamura Y., Yoshikawa M. Rubiscolin, a δ selective opioid peptide derived from plant Rubisco. FEBS Lett. 2001, 509(2):213-217.
49. Yang S., Kawamura Y., Yoshikawa M. Effect of rubiscolin, a δ opioid peptide derived from Rubisco, on memory consolidation. Peptides 2003, 24(2):325-328.
50. Yoshikawa M., Yoshimatsu T., Chiba H. Opioid peptides from human β-casein. Agric. Biol. Chem. 1984, 48:3185-3187.
51. 2 exhibits anxiolytic-like activity via the DP1 receptor in mice. Prostaglandins Other Lipid Mediat. 2009, 88(3-4):68-72.